"The novel mutations in spike may contribute to increased transmissibility, and could result in greater reinfection rates or reduced vaccine efficacy, the researchers reported. Their analysis showed that Pfizer serum samples were about 3-fold more resistant to neutralization, and Moderna samples were about 2.3-fold more resistant. Convalescent plasma was about 3.3-fold more resistant, while Regeneron's monoclonal antibody combination had no loss of antibody titer, the group said.
"The typical titer for someone who is vaccinated is 1:2,000," Landau told MedPage Today. "You can take that down to 1:500 and it will still kill the virus. ... Natural infection titers tend to be 1:200, on average, and that's still protective."
"We've done this for Alpha, Beta, Gamma, Delta, and now Lambda," Landau added. "The results we see are very similar for all these variants. We're primarily looking at the mRNA vaccines, and vaccine-elicited antibodies do a good job of neutralizing all the variants."
https://www.medpagetoday.com/special-reports/exclusives/93458?xid=nl_mpt_DHE_2021-07-08&eun=g1700464d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%20Top%20Cat%20HeC%20%202021-07-08&utm_term=NL_Daily_DHE_dual-gmail-definition&fbclid=IwAR2iymxF3y_CoQ-YWM3ZM0CmkrHOgDVecMPc93kSSE8zEafI7toOdl76u78
Comments
Post a Comment